New‐onset atypical fulminant type 1 diabetes after COVID‐19 vaccination: A case report

Takaaki Kobayashi,Fumiyoshi Yakou,Masuo Saburi,Ai Hirose,Hiroaki Akaoka,Yusuke Hirota,Daisuke Yunaiyama,Nobuteru Asahi,Atsushi Ohno,Takaya Matsushita

Clinical Case Reports（2022）

引用 6|浏览2

暂无评分

摘要

Adverse reactions, including the onset of diabetes, after coronavirus disease 2019 (COVID-19) vaccination have been reported. Herein, we report a case of a man who developed anti-glutamic acid decarboxylase (GAD) antibody-positive fulminant type 1 diabetes 15 weeks after COVID-19 vaccination, atypical of the previously reported anti-GAD antibody-negative cases.

查看译文

关键词

COVID‐19 vaccination,anti‐glutamic acid decarboxylase (GAD) antibody,diabetic ketoacidosis,fulminant type 1 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要